01 RUFINAMIDE (3)
01 EISAI INC (3)
01 TABLET;ORAL (3)
01 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 200MG (1)
03 400MG (1)
01 USA (3)
19
Eisai Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUFINAMIDE, with a corresponding application number 21911 and regulatory information .
proudly manufactured in the
approval since 2008-11-14
Eisai Inc's BANZEL TABLET;ORAL, medication with 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of RUFINAMIDE.
18
Eisai Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUFINAMIDE, with a corresponding application number 21911 and regulatory information .
proudly manufactured in the
approval since 2008-11-14
Eisai Inc's BANZEL TABLET;ORAL, medication with 200MG of RUFINAMIDE.
17
Eisai Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUFINAMIDE, with a corresponding application number 21911 and regulatory information .
proudly manufactured in the
approval since 2008-11-14
Eisai Inc's BANZEL TABLET;ORAL, medication with 400MG of RUFINAMIDE.